Home The Cove at Oyster Point

The Cove at Oyster Point

6 Articles
national-cancer-institute-2fyeLhUeYpg-unsplash(1)
FinanceINDUSTRY newsLife Science

Surrozen Extends 33,000 SQFT Lease in South San Francisco Another Four Years

By Kate Snyder In South San Francisco, a biotechnology company is extending its lease at a life science and office hub. Surrozen, Inc.,...

CommercialFinanceINDUSTRY newsLife Science

Pfizer Lists 91,000 SQFT for Sublease in South San Francisco Oyster Point Building

By Kate Snyder Nearly 100,000 square feet of life science and office space has hit the sublease market in South San Francisco. Pfizer...

FinanceINDUSTRY newsLife Science

Pliant Therapeutics Finalizes Lease Deal for 101,000 SQFT in South San Francisco

By The Registry Staff A clinical-stage pharmaceutical firm is making changes to its office space arrangements. Pliant Therapeutics, a company specializing in treatments...

CommercialINDUSTRY news

Sutro Biopharma Takes 115,000 SQFT Sublease in South San Francisco

By Vladimir Bosanac The life science sector continues to be alive and well in the Bay Area. In a transaction reminiscent of a...

CommercialFinanceINDUSTRY news

HCP Buys Life Science Property in South San Francisco for $83MM

By Jon Peterson Irvine-based HCP has paid $83 million or $488 per square foot to buy the 170,000 square foot Edgewater Science &...

News Releases

HCP Breaks Ground on the Second Phase of the Cove at Oyster Point in South San Francisco, Fueled by Strong Demand and Record Low Vacancy Rates

IRVINE and SAN FRANCISCO, CA – Jan. 29, 2016 – HCP (NYSE:HCP) and CBRE Group, Inc. announced today that HCP will break ground...

Partner Content

2026 Northern California CRE Rising Stars

NorCal rising stars 2026

Partner Content


Recent Posts

Social Media Auto Publish Powered By : XYZScripts.com